Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             54 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A Database Quality Review Process with Interim Checks Brunelle, Rocco
 2002
 36 2 p. 357-367
 artikel
2 A Database Quality Review Process with Interim Checks Brunelle, Rocco
36 2 p. 357-367
 artikel
3 Adverse Event Reporting and Standardized Medical Terminologies: Strengths and Limitations Goldman, Stephen A.
 2002
 36 2 p. 439-444
 artikel
4 Adverse Event Reporting and Standardized Medical Terminologies: Strengths and Limitations Goldman, Stephen A.
36 2 p. 439-444
 artikel
5 Aggregate Analysis of the Export Petition and Waiver Process: A Pharmaceutical Industry Perspective Fisher, Travis S.
 2002
 36 2 p. 343-348
 artikel
6 Aggregate Analysis of the Export Petition and Waiver Process: A Pharmaceutical Industry Perspective Fisher, Travis S.
36 2 p. 343-348
 artikel
7 Analysis of the Qt Interval in Clinical Trials Dmitrienko, Alex
 2002
 36 2 p. 269-279
 artikel
8 Analysis of The QT Interval in Clinical Trials Dmitrienko, Alex
36 2 p. 269-279
 artikel
9 A Nonparametric Method for Combining Multilaboratory Data Huang, Jie
 2002
 36 2 p. 395-406
 artikel
10 A Nonparametric Method for Combining Multilaboratory Data Huang, Jie
36 2 p. 395-406
 artikel
11 Are Commercial Disease Managers Willing and Prepared to Enter the Medicare Market?* Cohen, Joshua
 2002
 36 2 p. 445-452
 artikel
12 Are Commercial Disease Managers Willing and Prepared to Enter the Medicare Market? Cohen, Joshua
36 2 p. 445-452
 artikel
13 A Review of Current Events in Human Subjects Protection Coleman, Laura
 2002
 36 2 p. 261-267
 artikel
14 A Review of Current Events in Human Subjects Protection Coleman, Laura
36 2 p. 261-267
 artikel
15 Assessment of the Immunotoxic Potential of Human Pharmaceuticals: A Workshop Report Putman, Esther
 2002
 36 2 p. 417-427
 artikel
16 Assessment of the Immunotoxic Potential of Human Pharmaceuticals: A Workshop Report Putman, Esther
36 2 p. 417-427
 artikel
17 505(b)(2) Applications: History, Science, and Experience* Johnston, Gordon
 2002
 36 2 p. 319-323
 artikel
18 505(b)(2) Applications: History, Science, and Experience Johnston, Gordon
36 2 p. 319-323
 artikel
19 Bridging Data between Two Ethnic Populations. A New Application of Matched Case-Control Methodology Sarkar, Somnath
 2002
 36 2 p. 349-356
 artikel
20 Bridging Data between Two Ethnic Populations. A New Application of Matched Case-Control Methodology Sarkar, Somnath
36 2 p. 349-356
 artikel
21 Clinical Trials: Focus on Italy Bianchi, Walter
 2002
 36 2 p. 387-394
 artikel
22 Clinical Trials: Focus on Italy Bianchi, Walter
36 2 p. 387-394
 artikel
23 Comparison of Additional Regulatory Requirements for Conducting Clinical Trials on Genetically-Modified Microorganisms and Recombinant Dna in Europe, the United States, and Canada Lee, King C.
 2002
 36 2 p. 379-386
 artikel
24 Comparison of Additional Regulatory Requirements for Conducting Clinical Trials on Genetically-Modified Microorganisms and Recombinant DNA in Europe, the United States, and Canada Lee, King C.
36 2 p. 379-386
 artikel
25 Deceptive Inquiries Made to Drug Information Departments Curran, Charles F.
 2002
 36 2 p. 435-438
 artikel
26 Deceptive Inquiries Made to Drug Information Departments Curran, Charles F.
36 2 p. 435-438
 artikel
27 Ethical Concerns in Placebo-Controlled Studies: An Analytical Approach* Cavazos, Nora
 2002
 36 2 p. 249-259
 artikel
28 Ethical Concerns in Placebo-Controlled Studies: An Analytical Approach Cavazos, Nora
36 2 p. 249-259
 artikel
29 Evaluation of Published Case Reports' Standards and Notification Ferguson, Jeffrey A.
 2002
 36 2 p. 303-307
 artikel
30 Evaluation of Published Case Reports’ Standards and Notification Ferguson, Jeffrey A.
36 2 p. 303-307
 artikel
31 From the Editor-In-Chief: “Regulatory Reform at a Crossroads” Kaitin, Kenneth I.
 2002
 36 2 p. 245-246
 artikel
32 From the Editor-in-Chief: “Regulatory Reform at a Crossroads” Kaitin, Kenneth I.
36 2 p. 245-246
 artikel
33 Guest Editor's Note: Regulatory Affairs Copmann, Thomas L.
 2002
 36 2 p. 247-248
 artikel
34 Guest Editor’s Note: Regulatory Affairs Copmann, Thomas L.
36 2 p. 247-248
 artikel
35 Japanese Perspectives on Pharmaceutical Product Release Rate Testing Kaniwa, Nahoko
 2002
 36 2 p. 407-415
 artikel
36 Japanese Perspectives on Pharmaceutical Product Release Rate Testing Kaniwa, Nahoko
36 2 p. 407-415
 artikel
37 Managing a Crisis Effectively: A Blueprint for Pharmaceutical Companies Stotka, Jennifer L.
 2002
 36 2 p. 325-331
 artikel
38 Managing a Crisis Effectively: A Blueprint for Pharmaceutical Companies Stotka, Jennifer L.
36 2 p. 325-331
 artikel
39 Prescription-to-Over-the-Counter Switch Criteria Soller, R. William
 2002
 36 2 p. 309-317
 artikel
40 Prescription-to-over-the-Counter Switch Criteria Soller, R. William
36 2 p. 309-317
 artikel
41 Pricing Policies in the Pharmaceutical Sector Capri, Stefano
 2002
 36 2 p. 453-464
 artikel
42 Pricing Policies in the Pharmaceutical Sector Capri, Stefano
36 2 p. 453-464
 artikel
43 Standard Operating Procedures for Clinical Research Coordinators Fries, Ruth Ann
 2002
 36 2 p. 369-377
 artikel
44 Standard Operating Procedures for Clinical Research Coordinators Fries, Ruth Ann
36 2 p. 369-377
 artikel
45 Taking the Package Insert into the Electronic Age* Smith, Neil V.
 2002
 36 2 p. 429-434
 artikel
46 Taking the Package Insert into the Electronic Age Smith, Neil V.
36 2 p. 429-434
 artikel
47 The Single Controlled Trial: Industry Survey Indicates That Implementation is Still a Work in Progress Milne, Christopher-Paul
 2002
 36 2 p. 291-302
 artikel
48 The Single Controlled Trial: Industry Survey Indicates that Implementation is Still a Work in Progress Milne, Christopher-Paul
36 2 p. 291-302
 artikel
49 The United States Food and Drug Administration's Risk Management Framework Steidle, Gina
 2002
 36 2 p. 333-341
 artikel
50 The United States Food and Drug Administration’s Risk Management Framework Steidle, Gina
36 2 p. 333-341
 artikel
51 Which Factors Shape and Limit the Role of the Center for Drug Evaluation and Research's Advisory Committees?* Schulman, Sara
 2002
 36 2 p. 281-289
 artikel
52 Which Factors Shape and Limit the Role of the Center for Drug Evaluation and Research’s Advisory Committees? Schulman, Sara
36 2 p. 281-289
 artikel
53 Will Data Privacy Impact Health Research? Knudsen, Lisbeth Ehlert
 2002
 36 2 p. 465-480
 artikel
54 Will Data Privacy Impact Health Research? Knudsen, Lisbeth Ehlert
36 2 p. 465-480
 artikel
                             54 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland